If you are over 30 and live in Australia, you may know the pattern well: you fall asleep exhausted, then wake at 2–3 a.m. with your mind racing. Or you feel on edge in social situations, dread Monday meetings, or find that menopause has stolen your sleep. Maybe you have already tried an SSRI and felt emotionally numb, gained weight, or lost interest in sex. Maybe you fear benzodiazepines because a friend became dependent. These are real pain points, and they are exactly why many Australian doctors look to trazodone.
Trazodone is not new, but it is experiencing a quiet revival because it treats several problems at once: poor sleep, low mood, anxiety, hot flushes, and even some prostate-related sleep disruption—without many of the side effects that make people stop other antidepressants.
Trazodone belongs to a class called serotonin antagonist and reuptake inhibitors (SARIs). It increases serotonin but also blocks certain serotonin receptors, which produces a calming, sleep-promoting effect. Unlike older tricyclic antidepressants, it has much less anticholinergic burden, and unlike benzodiazepines, it is not a controlled drug and has far lower dependence potential.
| Feature | What it means in practice |
|---|---|
| Drug class | SARI — serotonin modulator with sedative properties |
| Common dose range | 50–150 mg at night for sleep and anxiety; up to 300 mg/day for depression under specialist review |
| PBS status | Subsidised for major depression; check current PBS criteria with your GP |
| Key benefits | Improves deep sleep, less sexual dysfunction, less weight gain, less anticholinergic load than older drugs |
| Main cautions | Morning grogginess, dizziness, rare priapism, serotonin interactions, alcohol increases sedation |
| Pregnancy | TGA Category C — discuss with your doctor before pregnancy |
Many Australian GPs now use trazodone off-label at low dose for insomnia, generalised anxiety, and menopausal sleep disturbance, even when a person does not meet full criteria for major depression.
SSRIs such as sertraline or escitalopram help many people, but they can cause sexual difficulties, emotional blunting, and weight gain. Trazodone is less likely to do this, and because it is taken at night, it targets the sleep disturbance that drives morning fatigue and irritability. For the over-30 professional, parent, or shift worker, better sleep often translates into better mood, focus, and relationships.
One concern many patients have is dependence and withdrawal. Trazodone is not a benzodiazepine, but stopping it suddenly after long-term use can cause rebound insomnia, anxiety, dizziness, and irritability. That is why a gradual taper is essential. Below is a typical schedule for a person on 150 mg at night; your doctor may slow this further if you have been on it for years.
| Step | Dose | Duration | Practical notes |
|---|---|---|---|
| 1 | 150 mg → 100 mg at night | 7–14 days | Watch for rebound anxiety or poor sleep |
| 2 | 100 mg → 50 mg at night | 7–14 days | Use 50 mg tablet; continue sleep hygiene |
| 3 | 50 mg → 25 mg at night | 7–14 days | Half a scored 50 mg tablet; use only if tolerated |
| 4 | 25 mg → stop | — | If withdrawal symptoms appear, hold at current dose and contact your GP |
For high-dose or long-term use, reduce by 50 mg every 2–4 weeks. Never stop abruptly.
Men over 50 often wake several times a night to urinate due to benign prostate enlargement. Trazodone has alpha-1 blocking activity, which can relax the bladder neck and prostate smooth muscle, potentially easing urinary flow. It also has much less anticholinergic effect than older antidepressants, so it is generally less likely to cause urinary retention. However, individual responses vary: some men may experience dizziness or, rarely, retention. If you already take an alpha blocker such as tamsulosin, your GP will monitor blood pressure and urinary symptoms carefully.
Social anxiety disorder is common but under-treated in Australia. SSRIs and SNRIs are first-line, but trazodone has a role. Research evidence specifically for social anxiety is modest—fewer controlled trials than for depression or generalised anxiety—but its serotonergic and sleep-improving effects can reduce the anticipatory anxiety and exhaustion that often accompany social situations. In clinical practice, Australian doctors may use trazodone as an alternative or add-on when SSRIs cause sexual side effects or when insomnia is a major driver of social avoidance.
For many Australian women, menopause brings hot flushes and night sweats that fragment sleep and worsen mood. Low-dose trazodone at night has been used off-label to reduce nocturnal hot flush awakenings and improve sleep quality. It is not a hormone replacement and not PBS-listed for hot flushes, so it may be prescribed privately. Still, for women who cannot or prefer not to use hormones, it can be a practical option.
In Australia, trazodone is classified as TGA Pregnancy Category C. This means its safety in human pregnancy has not been established, and it may have pharmacological effects on the fetus or neonate. The classification does not mean it is absolutely forbidden, but any use during pregnancy should occur only after a careful discussion with your GP or perinatal psychiatrist, weighing the risks of untreated depression against potential medication effects. If you are planning pregnancy, review your medications before conception.
One reason doctors choose trazodone for patients with a history of suicidal thinking is its relative safety in overdose compared with older tricyclic antidepressants. There is no single “lethal dose” that applies to everyone. Serious toxicity in humans is usually associated with doses above 2–3 g (2000–3000 mg), but outcomes depend on weight, age, heart health, and co-ingestants. Trazodone alone is much less cardiotoxic than older drugs, but mixing it with alcohol, opioids, or benzodiazepines greatly increases risk. Any suspected overdose is a medical emergency—call 000 or the Poisons Information Centre on 13 11 26.
If you take trazodone for depression, anxiety, or sleep, you must disclose it when applying for life, income protection, or travel insurance. Under the Insurance Contracts Act 1984 (Cth), non-disclosure can allow the insurer to reduce or refuse a claim, even if the medication seems unrelated. Disclosing trazodone does not mean automatic rejection; insurers will usually assess the underlying condition, dose, stability, and your GP’s report. Honesty is the safest approach.
For Aboriginal and Torres Strait Islander Australians, depression, anxiety, and sleep problems often occur alongside chronic disease, grief, and barriers to accessing care. Trazodone’s once-nightly sedation can be useful, but prescribing must be culturally safe. GPs working with Aboriginal Health Workers and Aboriginal Community Controlled Health Organisations often start low, review kidney and liver function, consider alcohol use, and ensure clear communication about side effects and follow-up. PBS subsidies and Closing the Gap programs can improve access, but medicine alone is only part of a holistic plan.
If any of this sounds familiar—broken sleep, social anxiety, hot flushes, prostate-related waking, or an antidepressant that has not worked for you—trazodone may be worth discussing with your GP. Here is how to make the most of that visit:
Trazodone is not for everyone, but for the right patient it can restore the sleep, mood, and calm that have been missing. If you are ready to move beyond broken nights and exhausting days, book an appointment with your Australian GP and ask whether trazodone is a suitable option for you.
Disclaimer: This article is for educational purposes and does not replace individual medical advice. Trazodone is a prescription-only medicine in Australia. Always consult a qualified health professional before starting, changing, or stopping any medication.